BioAmber (BIOA) Tops Q3 EPS by 18c

BioAmber (NYSE: BIOA) reported Q3 revenue for the quarter came in at $631 thousand versus the consensus estimate of $3.78 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
• Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight